1. Home
  2. BBW vs STRO Comparison

BBW vs STRO Comparison

Compare BBW & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBW

Build-A-Bear Workshop Inc.

HOLD

Current Price

$37.35

Market Cap

444.3M

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$29.38

Market Cap

524.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBW
STRO
Founded
1997
2003
Country
United States
United States
Employees
N/A
133
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
444.3M
524.8M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
BBW
STRO
Price
$37.35
$29.38
Analyst Decision
Strong Buy
Buy
Analyst Count
7
9
Target Price
$67.71
$31.33
AVG Volume (30 Days)
334.4K
291.3K
Earning Date
05-28-2026
05-11-2026
Dividend Yield
2.51%
N/A
EPS Growth
5.00
N/A
EPS
3.99
N/A
Revenue
$357,866,000.00
N/A
Revenue This Year
$5.63
N/A
Revenue Next Year
$4.62
N/A
P/E Ratio
$9.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.08
$0.67
52 Week High
$75.77
$43.85

Technical Indicators

Market Signals
Indicator
BBW
STRO
Relative Strength Index (RSI) 49.45 42.12
Support Level $35.31 $10.50
Resistance Level $39.71 $43.85
Average True Range (ATR) 1.95 3.21
MACD 0.32 -1.22
Stochastic Oscillator 53.61 22.83

Price Performance

Historical Comparison
BBW
STRO

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments: Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, U.K., Ireland, and two e-commerce sites, the international franchising segment includes royalties and product and fixture sales from other international operations under franchise agreements, and the commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: